abstract |
A compositions of matter and pharmaceutical compositions are disclosed, which in various embodiments, comprise biologically active glycosylated peptides that can be used therapeutically or prophylactically against diseases or conditions linked to bradykinin B1 receptor as the causative agent. A method of treating, preventing, or ameliorating a disease or condition associated with B1 activity is also disclosed. |